These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27670281)

  • 41. Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series.
    Andersen JD; Bünger MH; Rahbek O; Hald JD; Harsløf T; Langdahl BL
    Osteoporos Int; 2019 Feb; 30(2):513-517. PubMed ID: 30448959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bisphosphonates and the risk of atypical femur fractures.
    Black DM; Condra K; Adams AL; Eastell R
    Bone; 2022 Mar; 156():116297. PubMed ID: 34920168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.
    Miller PD; McCarthy EF
    Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the Nature and Etiologies of Risk Factors for Diaphyseal Atypical Femoral Fractures.
    Tsuchie H; Miyakoshi N; Kasukawa Y; Nozaka K; Saito K; Kinoshita H; Kobayashi M; Suzuki N; Aizawa T; Abe H; Maekawa S; Tomite T; Ono Y; Ouchi K; Shibata N; Nagahata I; Takeshima M; Akagawa M; Yuasa Y; Sato C; Shimada Y
    Med Princ Pract; 2021; 30(5):430-436. PubMed ID: 34058735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Femoral Bowing and Femoral Neck-Shaft Angle Evaluation Can Reduce Atypical Femoral Fractures in Osteoporotic Patients: A Scientific Report.
    Papaioannou I; Pantazidou G; Baikousis A; Korovessis P
    Cureus; 2020 Oct; 12(10):e10771. PubMed ID: 33154843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in femur geometry and bone markers in atypical femur fractures and the general population.
    Jung IJ; Kim JW
    Sci Rep; 2021 Dec; 11(1):24149. PubMed ID: 34921200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.
    Mawatari T; Ikemura S; Matsui G; Iguchi T; Mitsuyasu H; Kawahara S; Maehara M; Muraoka R; Iwamoto Y; Nakashima Y
    Bone Rep; 2020 Jun; 12():100275. PubMed ID: 32462056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluating Atypical Features of Femur Fractures: How Change in Radiological Criteria Influenced Incidence and Demography of Atypical Femur Fractures in a Community Setting.
    LeBlanc ES; Rosales AG; Black DM; Genant HK; Dell RM; Friess DM; Boardman DL; Bauer DC; de Papp A; Santora AC; Orwoll ES
    J Bone Miner Res; 2017 Nov; 32(11):2304-2314. PubMed ID: 28731209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical femur fracture during bisphosphonate drug holiday: a case series.
    Lovy AJ; Koehler SM; Keswani A; Joseph D; Hasija R; Ghillani R
    Osteoporos Int; 2015 Jun; 26(6):1755-8. PubMed ID: 25832177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unique Form of Atypical Subtrochanteric Femoral Fracture at the Medial Cortex: A Report of 3 Cases.
    Roh YH; Kim KH; Yoon KS; Ha YC; Yoo SJ; Nam KW
    JBJS Case Connect; 2020; 10(3):e19.00545. PubMed ID: 32865952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence and bone biopsy findings of atypical femoral fractures.
    Tamminen IS; Yli-Kyyny T; Isaksson H; Turunen MJ; Tong X; Jurvelin JS; Kröger H
    J Bone Miner Metab; 2013 Sep; 31(5):585-94. PubMed ID: 23553501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis.
    Vasikaran SD; Miura M; Pikner R; Bhattoa HP; Cavalier E;
    Calcif Tissue Int; 2023 Feb; 112(2):148-157. PubMed ID: 34846540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiresorptives: Safety Concerns-Clinical Perspective.
    Brown JP
    Toxicol Pathol; 2017 Oct; 45(7):859-863. PubMed ID: 29065818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
    Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
    N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Sato H; Kondo N; Nakatsue T; Wada Y; Fujisawa J; Kazama JJ; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
    Osteoporos Int; 2017 Aug; 28(8):2367-2376. PubMed ID: 28409215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atypical fractures: An issue of concern or a myth?
    Al-Ashqar M; Panteli M; Chakrabarty G; Giannoudis PV
    Injury; 2018 Mar; 49(3):649-655. PubMed ID: 29338853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical Fractures of the Femur Associated with Chronic Treatment with Bisphosphonates.
    Fijewski G; Szostakowski B; Górski R; Modzelewski P; Dudek P; Małdyk P
    Ortop Traumatol Rehabil; 2016 May; 18(3):239-249. PubMed ID: 28157080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.
    Nishimukai A; Higuchi T; Ozawa H; Yanai A; Miyagawa Y; Murase K; Imamura M; Takatsuka Y; Miyoshi Y
    Breast Cancer; 2017 Mar; 24(2):245-253. PubMed ID: 27040403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequency and associated factor of atypical periprosthetic femoral fracture after hip arthroplasty.
    Lee YK; Park CH; Kim KC; Hong SH; Ha YC; Koo KH
    Injury; 2018 Dec; 49(12):2264-2268. PubMed ID: 30245278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.